Search
SOLACI Congress
HomeInternational CongressesTCT 2015

TCT 2015

View Category
Day 3

PANDA III: stent liberador de sirolimus con polímero reabsorbible.

Bo Xu
solaci -
Learn More
Day 3

ISAR-DESIRE 4: Balón liberador de paclitaxel en reestenosis intrastent de un DES.

Fundamentos: O objetivo desse estudo apresentado na sessão First Report Investigations foi comparar a eficácia anti reestenose da...
solaci -
Learn More
Day 3

LEADERS FREE: Un mes de doble antiagregación parece suficiente en pacientes de alto riesgo de sangrado tratados con el stent liberados de biolimus con...

Philip M. Urban
solaci -
Learn More
Day 3

TUXEDO: stent liberador de paclitaxel no alcanzó la no inferioridad en pacientes diabéticos vs el stent liberador de everolimus.

Upendra Kaul
solaci -
Learn More
Day 2

PLATAFORM: FFR por angiotomografía en pacientes sintomáticos con probabilidad intermedia de enfermedad coronaria.

Mark Andrew Hlatky
solaci -
Learn More
Day 2

RIVER-PCI: La Ranolazina no disminuye la tasa de re hospitalización o revascularización en pacientes con angina crónica y revascularización incompleta

Giora Weisz
solaci -
Learn More
Day 2

TOTAL: La aspiración de rutina en la angioplastia primaria no mejora los resultados y podría aumentar el riesgo de accidente cerebro vascular.

Sanjit S. Jolly
solaci -
Learn More
Day 2

EXPLORE: Recanalización de oclusión total crónica de vaso no culpable luego de un infarto.

Jose P.S. Henriques
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Evolution of Small Balloon-Expandable Valves

Dr. Carlos Fava - 0
Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

solaci - 0
Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

Institutional News

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

solaci - 0
The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy